Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 3/20 | 0.43 |
| ▸ | CASP3 | P42574 | 4/20 | 0.43 |
| ▸ | CASP1 | P29466 | 3/20 | 0.43 |
| ▸ | CASP9 | P55211 | 2/20 | 0.43 |
| ▸ | CASP7 | P55210 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.39 |
| ▸ | ELANE | P08246 | 2/20 | 0.39 |
| ▸ | TACR1 | P25103 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8361282 | 0.88 | CTSD (0.47) | CTSDCASP3CASP1CASP9CASP7 | |
| SCHEMBL8366184 | 0.82 | CTSD (0.43) | CTSDCASP3CASP1CASP9CASP7 | |
| SCHEMBL8366143 | 0.79 | CTSD (0.45) | CTSDCASP3CASP7 | |
| SCHEMBL8492203 | 0.77 | CTSD (0.54) | CTSDCASP3CASP7CAPN1ELANE | |
| SCHEMBL7806370 | 0.73 | CTSD (0.49) | CTSDCASP3CASP7TACR1 | |
| SCHEMBL23234582 | 0.72 | ALDH1A1 (0.59) | CTSDCASP3CASP7CAPN1TACR1 | |
| SCHEMBL6269817 | 0.72 | CTSD (0.59) | CTSDCASP3CASP7TACR1 | |
| SCHEMBL8736216 | 0.72 | CTSD (0.53) | CTSD | |
| SCHEMBL3058668 | 0.71 | ECE1 (0.61) | CTSDCASP3CASP7CAPN1TACR1 | |
| SCHEMBL25287172 | 0.71 | ECE1 (0.61) | CTSDCASP3CASP7CAPN1TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0717731-B1 | DIFLUORO STATONE ANTIVIRAL ANALOGS | MERRELL PHARMA INC (US) | 1999-04-21 | — | — | EP | claimed |